πŸ‡ΊπŸ‡Έ FDA
Patent

US 6994868

Compositions useful as inhibitors of ERK

expired A61KA61K31/4155A61K31/4439

Quick answer

US patent 6994868 (Compositions useful as inhibitors of ERK) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/4155, A61K31/4439, A61K31/497, A61K31/501